Cargando…
Activating JAK1 mutation may predict the sensitivity of JAK-STAT inhibition in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the fifth most common type of cancers worldwide. However, current therapeutic approaches for this epidemic disease are limited, and its 5-year survival rate hasn't been improved in the past decades. Patient-derived xenograft (PDX) tumor models have become an ex...
Autores principales: | Yang, Shuqun, Luo, Chonglin, Gu, Qingyang, Xu, Qiang, Wang, Guan, Sun, Hongye, Qian, Ziliang, Tan, Yexiong, Qin, Yuxin, Shen, Yuhong, Xu, Xiaowei, Chen, Shu-Hui, Chan, Chi-Chung, Wang, Hongyang, Mao, Mao, Fang, Douglas D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868698/ https://www.ncbi.nlm.nih.gov/pubmed/26701727 http://dx.doi.org/10.18632/oncotarget.6684 |
Ejemplares similares
-
JAK/STAT signaling in hepatocellular carcinoma
por: Hin Tang, Justin Jit, et al.
Publicado: (2020) -
JAKs and STATs in chemoresistance
por: Costa-Pereira, Ana P
Publicado: (2010) -
JAK-STAT and feeding
por: Ladyman, Sharon R., et al.
Publicado: (2013) -
The Interaction Between Autophagy and JAK/STAT3 Signaling Pathway in Tumors
por: Xu, Jiangyan, et al.
Publicado: (2022) -
An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
por: Lensing, Maddison, et al.
Publicado: (2022)